ONYX — Onyx Biotec Balance Sheet
0.000.00%
- IN₹670.89m
- IN₹782.23m
- IN₹694.69m
Annual balance sheet for Onyx Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.136 | 0.074 | 14.7 | 86.1 | 40.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 110 | 53.2 | 156 | 204 | 283 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 144 | 146 | 296 | 492 | 513 |
| Net Property, Plant And Equipment | 213 | 425 | 435 | 409 | 428 |
| Other Long Term Assets | |||||
| Total Assets | 368 | 587 | 741 | 912 | 952 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 100 | 202 | 226 | 257 | 325 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 205 | 405 | 493 | 356 | 397 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 164 | 182 | 249 | 556 | 554 |
| Total Liabilities & Shareholders' Equity | 368 | 587 | 741 | 912 | 952 |
| Total Common Shares Outstanding |